SB
Silvia Bio
United Kingdom · Biotech
Cell profiling and media additives for more predictable biopharmaceutical manufacturing.
Product
Silvia Bio identifies biological processes that limit the performance of mammalian cells used to manufacture medicines. It uses those findings to formulate additives compatible with existing bioreactors.
The Sheffield university spinout offers cell-profiling services and licenses media additives designed to improve production yield and quality. Its approach targets manufacturing bottlenecks without requiring manufacturers to replace their production systems.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Seed | £3M | Northern Gritstone — LeadParkwalk Northern Universities Venture Fund — ParticipantUK Innovation and Science Seed Fund — ParticipantWren Capital — Participant |